Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare, progressive pulmonary
vascular disease that is usually a consequence of prior acute pulmonary embolism. CTEPH …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

PEA. They might be classified as cases of chronic thromboembolic pulmonary vascular
disease. Although current practice in major centers is to perform exercise tests, there is still …

Acute pulmonary embolism generally resolves within 6 months. However, if the thrombus is
infected, venous thrombi transform into fibrotic vascular obstructions leading to chronic deep …

Background Left-sided heart disease (LHD) is the most common cause of pulmonary
hypertension (PH). In patients with LHD, elevated left atrial pressure causes a passive …

Traditional concepts of the pathogenesis of chronic thromboembolic pulmonary
hypertension (CTEPH) invoke a thromboembolic origin. However, neither classic plasmatic …

Chronic Thromboembolic Pulmonary Hypertension | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …

Uncontrolled and controlled clinical trials with different compounds and procedures are
reviewed to define the risk-benefit profiles for therapeutic options in pulmonary arterial …

Long-term follow-up studies have consistently demonstrated that after an episode of acute
pulmonary embolism (PE), half of patients report functional limitations and/or decreased …

Chronic thromboembolic pulmonary hypertension (CTEPH) is a late sequel of venous
thromboembolism that cannot be completely reproduced in animal models. The prevalence …